Kathleen Sereda Glaub - Net Worth and Insider Trading
Kathleen Sereda Glaub Net Worth
The estimated net worth of Kathleen Sereda Glaub is at least $256,042 dollars as of 2024-11-13. Kathleen Sereda Glaub is the Director of Codexis Inc and owns about 63,534 shares of Codexis Inc (CDXS) stock worth over $256,042. Details can be seen in Kathleen Sereda Glaub's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen Sereda Glaub has not made any transactions after 2018-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kathleen Sereda Glaub
Kathleen Sereda Glaub Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathleen Sereda Glaub owns 3 companies in total, including Aligos Therapeutics Inc (ALGS) , Codexis Inc (CDXS) , and IO Biotech Inc (IOBT) .
Click here to see the complete history of Kathleen Sereda Glaub’s form 4 insider trades.
Insider Ownership Summary of Kathleen Sereda Glaub
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALGS | Aligos Therapeutics Inc | 2020-10-15 | director |
| CDXS | Codexis Inc | 2018-09-25 | director |
| IOBT | IO Biotech Inc | 2021-11-04 | director |
Kathleen Sereda Glaub Latest Holdings Summary
Kathleen Sereda Glaub currently owns a total of 1 stock. Kathleen Sereda Glaub owns 63,534 shares of Codexis Inc (CDXS) as of September 25, 2018, with a value of $256,042.
Latest Holdings of Kathleen Sereda Glaub
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDXS | Codexis Inc | 2018-09-25 | 63,534 | 4.03 | 256,042 |
Holding Weightings of Kathleen Sereda Glaub
Kathleen Sereda Glaub Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathleen Sereda Glaub has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the sale of 14,492 shares on September 25, 2018, which brought Kathleen Sereda Glaub around $272,884.
Insider Trading History of Kathleen Sereda Glaub
- 1
Kathleen Sereda Glaub Trading Performance
Kathleen Sereda Glaub Ownership Network
Ownership Network List of Kathleen Sereda Glaub
Ownership Network Relation of Kathleen Sereda Glaub
Kathleen Sereda Glaub Owned Company Details
What does Aligos Therapeutics Inc do?
Who are the key executives at Aligos Therapeutics Inc?
Kathleen Sereda Glaub is the director of Aligos Therapeutics Inc. Other key executives at Aligos Therapeutics Inc include 10 percent owner Roche Holding Ltd , 10 percent owner Roche Finance Ltd , and Chief Medical Officer Matthew W. Mcclure .
Aligos Therapeutics Inc (ALGS) Insider Trades Summary
Over the past 18 months, Kathleen Sereda Glaub made no insider transaction in Aligos Therapeutics Inc (ALGS). Other recent insider transactions involving Aligos Therapeutics Inc (ALGS) include a net purchase of 7,933,601 shares made by Carole Nuechterlein ,
In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 317,344 shares were bought by its insiders, resulting in a net purchase of 317,344 shares.
Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aligos Therapeutics Inc Insider Transactions
Kathleen Sereda Glaub Mailing Address
Above is the net worth, insider trading, and ownership report for Kathleen Sereda Glaub. You might contact Kathleen Sereda Glaub via mailing address: C/o Codexis, Inc., 200 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
